Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Rosiglitazone (Avandia) and macular edema.

Kendall C, Wooltorton E.

CMAJ. 2006 Feb 28;174(5):623. Epub 2006 Feb 8. No abstract available.

2.

Rosiglitazone and macular edema.

Sivagnanam G.

CMAJ. 2006 Aug 1;175(3):276. No abstract available.

3.

Cardiovascular risk of rosiglitazone: another perspective.

Waksman JC.

J Pharm Pharmacol. 2008 Dec;60(12):1573-82. doi: 10.1211/jpp.60.12.0002. Review.

PMID:
19000361
4.

Thiazolidinediones and the risk of edema: a meta-analysis.

Berlie HD, Kalus JS, Jaber LA.

Diabetes Res Clin Pract. 2007 May;76(2):279-89. Epub 2006 Oct 18.

PMID:
17055103
5.

Diabetic macular edema associated with glitazone use.

Ryan EH Jr, Han DP, Ramsay RC, Cantrill HL, Bennett SR, Dev S, Williams DF.

Retina. 2006 May-Jun;26(5):562-70.

PMID:
16770264
6.

How safe is the use of thiazolidinediones in clinical practice?

Rizos CV, Elisaf MS, Mikhailidis DP, Liberopoulos EN.

Expert Opin Drug Saf. 2009 Jan;8(1):15-32. doi: 10.1517/14740330802597821 . Review.

PMID:
19236215
7.

The truth about rosiglitazone (avandia).

Ledbetter C, Laustsen G.

Nurse Pract. 2008 Jun;33(6):10-1. Review. No abstract available.

PMID:
18528195
8.

Outlook on diabetes drug less than rosy. Early work suggests that rosiglitazone (Avandia) may not be best for the heart.

[No authors listed]

Harv Heart Lett. 2007 Aug;17(12):1-2. No abstract available.

PMID:
17717888
9.

Sirolimus-induced pneumonitis, sinusitis and macular oedema.

Nayak SK, Jeloka TK, Sreepada SV.

Nephrol Dial Transplant. 2004 Nov;19(11):2931. No abstract available.

PMID:
15496580
10.

Tolerability outcomes of a multicenter, observational, open-label, drug-surveillance study in patients with type 2 diabetes mellitus treated with pioglitazone for 2 years.

Grossman LD, Parlan G, Bailey AL, Yee G, Yu M, Chan JY.

Clin Ther. 2009 Jan;31(1):74-88. doi: 10.1016/j.clinthera.2009.01.004.

PMID:
19243708
11.

Physiogenomic comparison of edema and BMI in patients receiving rosiglitazone or pioglitazone.

RuaƱo G, Bernene J, Windemuth A, Bower B, Wencker D, Seip RL, Kocherla M, Holford TR, Petit WA, Hanks S.

Clin Chim Acta. 2009 Feb;400(1-2):48-55. doi: 10.1016/j.cca.2008.10.009. Epub 2008 Oct 26.

PMID:
18996102
12.

Fluid retention and vascular effects of rosiglitazone in obese, insulin-resistant, nondiabetic subjects.

Rennings AJ, Smits P, Stewart MW, Tack CJ.

Diabetes Care. 2006 Mar;29(3):581-7.

PMID:
16505510
13.

Comparison of vildagliptin and rosiglitazone monotherapy in patients with type 2 diabetes: a 24-week, double-blind, randomized trial.

Rosenstock J, Baron MA, Dejager S, Mills D, Schweizer A.

Diabetes Care. 2007 Feb;30(2):217-23. Erratum in: Diabetes Care. 2007 May;30(5):1330.

PMID:
17259484
14.

The controversial effects of thiazolidinediones on cardiovascular morbidity and mortality.

Stafylas PC, Sarafidis PA, Lasaridis AN.

Int J Cardiol. 2009 Jan 24;131(3):298-304. doi: 10.1016/j.ijcard.2008.06.005. Epub 2008 Aug 5. Review.

PMID:
18684530
15.

Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: the case of rosiglitazone.

Hernandez AV, Walker E, Ioannidis JP, Kattan MW.

Am Heart J. 2008 Jul;156(1):23-30. doi: 10.1016/j.ahj.2008.03.002. Epub 2008 May 5. Review.

PMID:
18585493
16.

Acute pulmonary edema due to rosiglitazone use in a patient with diabetes mellitus.

Cekmen N, Cesur M, Cetinbas R, Bedel P, Erdemli O.

J Intensive Care Med. 2006 Jan-Feb;21(1):47-50.

PMID:
16698744
17.

Thiazolidinedione-induced edema in patients with heart failure.

Stroup JS.

Am J Health Syst Pharm. 2007 Dec 1;64(23):2426-30; author reply 2430. No abstract available.

PMID:
18029947
18.

Novel drug delivery systems for retinal diseases. A review.

Lee SS, Robinson MR.

Ophthalmic Res. 2009;41(3):124-35. doi: 10.1159/000209665. Epub 2009 Mar 26. Review.

PMID:
19321933
19.

CSR-like presentation in epidemic dropsy.

Tandon R, Chandra P, Garg S, Verma L, Menon V.

Eye (Lond). 1999 Dec;13 ( Pt 6):802-5. No abstract available.

PMID:
10707156
20.

[Heart failure while taking glitazones--what do we know today?].

Halbritter R.

Dtsch Med Wochenschr. 2009 Jul;134(28-29):1488; author reply 1488. doi: 10.1055/s-0029-1225308. Epub 2009 Jul 1. German. No abstract available.

PMID:
19572255

Supplemental Content

Support Center